United Therapeutics Corporation
UTHRDrug Manufacturers - Specialty & Generic
$598.72+0.87%As of Oct 30vs prior close
- Market cap
- $25.7B
- P/E (TTM)
- 19.8×
- P/E (FY1)
- 21.5×
- From 52W high
- 0.00%
- EPS (LTM)
- $27.91
- Revenue (LTM)
- $3.2B
- Net margin
- 41.56%
- Dividend yield
- 0.00%
Nomior Score
79
Fortified DefenderTop 3% of the scored universe
Growth58
Quality79
Value60
Momentum74
Resilience69
Growth
+7.95%revenue a year over 9 fiscal years
YE16 $1.6BLTM $3.2B
Connections
Revenue to profitQ2 YE26
43% of revenue became net profit, up 4 pts on a year.
Who owns it
2funds